EN
抗体药类似物
Research Grade Atoltivimab
All
TD-VK623066_1.jpg
  • CatalogTD-VK623066
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsREGN-3470-3471-3479,REGN-3470/REGN-3471/REGN-3479,REGN-EB3,REGNEB3,Inmazeb(atoltivimab,maftivimab,odesivimab-ebgn),CAS:2135632-29-8
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Atoltivimab


Catalog No. TD-VK623066
Species reactivity Zaire ebolavirus (ZEBOV)
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Envelope glycoprotein, GP1,2, GP, Shed GP, GP1,2-delta, GP1, GP2, GP
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q05320
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names REGN-3470-3471-3479,REGN-3470/REGN-3471/REGN-3479,REGN-EB3,REGNEB3,Inmazeb(atoltivimab,maftivimab,odesivimab-ebgn),CAS:2135632-29-8
Background Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-VK623066_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Atoltivimab.